Free Trial
LON:FCSS

Fidelity China Special 12/9/2024 Earnings Report

Fidelity China Special logo
GBX 298.50 -7.00 (-2.29%)
As of 11:52 AM Eastern

Fidelity China Special EPS Results

Actual EPS
GBX 9.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Fidelity China Special Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fidelity China Special Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Fidelity China Special Earnings Headlines

Fidelity China Special Situations Plc - Directorate change
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
Fidelity China Special Situations Plc - Change of Auditor
Fidelity China Special Ord (FCSS.L) - Yahoo Finance
See More Fidelity China Special Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fidelity China Special? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fidelity China Special and other key companies, straight to your email.

About Fidelity China Special

As the world’s second-largest economy, China is shifting from export-led growth towards an economy driven by domestic consumption. With expanding middle classes, rising incomes and technological innovations driving this change and creating a solid backdrop for companies to thrive, investors seeking an effective globally diversified portfolio may want to consider allocating some of their portfolio to China. Fidelity China Special (LON:FCSS) Situations PLC provides focused exposure to companies benefiting from this growth opportunity. New consumer spending power and increasing aspirations underpin many of the portfolio’s investments alongside burgeoning industries such as e-commerce and healthcare.

View Fidelity China Special Profile